Trial Outcomes & Findings for Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy (NCT NCT00888979)

NCT ID: NCT00888979

Last Updated: 2017-01-09

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

10 participants

Primary outcome timeframe

Baseline to 4 weeks

Results posted on

2017-01-09

Participant Flow

Participant milestones

Participant milestones
Measure
Nicotrol Inhaler With Behavioral Counseling
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
Overall Study
STARTED
10
Overall Study
Received the Inhaler/Counseling
8
Overall Study
COMPLETED
6
Overall Study
NOT COMPLETED
4

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Nicotrol Inhaler With Behavioral Counseling
n=8 Participants
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
n=99 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
Age, Continuous
26 years
n=99 Participants
Gender
Female
8 Participants
n=99 Participants
Gender
Male
0 Participants
n=99 Participants
Region of Enrollment
United States
8 participants
n=99 Participants

PRIMARY outcome

Timeframe: Baseline to 4 weeks

Outcome measures

Outcome measures
Measure
Nicotrol Inhaler With Behavioral Counseling
n=6 Participants
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
Number of Days of Inhaler Use
26.4 days
Standard Deviation 3

SECONDARY outcome

Timeframe: Baseline to 4 weeks

Outcome measures

Outcome measures
Measure
Nicotrol Inhaler With Behavioral Counseling
n=6 Participants
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
Cartridge Use
2 cartridges per day
Standard Deviation 1.5

SECONDARY outcome

Timeframe: Baseline to 4 weeks

Outcome measures

Outcome measures
Measure
Nicotrol Inhaler With Behavioral Counseling
n=6 Participants
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
Change in Number of Cigarettes Used Per Day From Baseline to 4 Weeks.
-5.7 reduction in number of CPD
Standard Deviation 2.3

Adverse Events

Nicotrol Inhaler With Behavioral Counseling

Serious events: 1 serious events
Other events: 4 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Nicotrol Inhaler With Behavioral Counseling
n=8 participants at risk
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
Pregnancy, puerperium and perinatal conditions
preterm premature rupture of membranes
12.5%
1/8 • Number of events 1 • Baseline to delivery, up to 27 weeks)

Other adverse events

Other adverse events
Measure
Nicotrol Inhaler With Behavioral Counseling
n=8 participants at risk
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
Gastrointestinal disorders
Nausea
25.0%
2/8 • Number of events 2 • Baseline to delivery, up to 27 weeks)
Nervous system disorders
Headache
25.0%
2/8 • Number of events 3 • Baseline to delivery, up to 27 weeks)
General disorders
Lightheadedness
12.5%
1/8 • Number of events 1 • Baseline to delivery, up to 27 weeks)
Gastrointestinal disorders
heartburn
12.5%
1/8 • Number of events 1 • Baseline to delivery, up to 27 weeks)

Additional Information

Cheryl Oncken

UConn Health

Phone: 860-679-3425

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place